By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Intrexon Corporation (Research Triangle Park, NC) 

108 T.W. Alexander Drive
PO Box 14088
Research Triangle Park  North Carolina  27709  U.S.A.
Phone: n/a Fax: n/a

Founded in 1998, Intrexon Corporation is a privately held biotechnology company focused on the industrial engineering of synthetic biology. Intrexon is deploying its extensive capabilities to rapidly design and produce novel and enhanced biological products and processes across multiple industry sectors, including: human therapeutics, protein production, industrial products, agricultural biotechnology, and animal science. The company’s advanced bioindustrial engineering platform enables Better DNA™ technology by combining breakthroughs in DNA control systems with corresponding advancements in modular transgene design, assembly, and optimization to enable unprecedented control over the function and output of living cells.

Our mission is to redefine the biotechnology development process by engineering complex multigenic biological and cellular systems at unprecedented scale, dramatically reducing the time, cost, and risks associated with synthetic biology. With an extensive and expanding patent portfolio, Intrexon is working with key channel partners throughout our commercial divisions to utilize the industrial engineering of synthetic biology in developing new products and processes, which will alleviate shortages of essential nutrients, bring better medicines to more people, and generate renewable fuels and other resources. Our Better DNA™ technology provides the foundation to industrialize the development of high-performing biological products and enable many new possibilities across broad industries.

Intrexon’s commercial and core technology divisions are located within the country’s major biotechnology hotbeds. In California, San Francisco is the primary site of the Protein Production and Industrial Products Divisions, with our Cell Engineering Unit nearby in San Diego. Intrexon’s expansive Germantown, Maryland facility is centrally located within the Mid-Atlantic biotech region and is currently home to our Human Therapeutics and Animal Science Divisions, as well as our Molecular Engineering Unit. Corporate headquarters, as well as the UltraVector Technology Division are both located in Blacksburg, Virginia. Finally, the southern states host a second site for our Protein Production Division in Charleston, South Carolina, in addition to our Agricultural Biotech Division in Research Triangle Park, North Carolina.

We are always seeking those who share our passion for excellence, hard work, creativity, and moving beyond the limitations of traditional biotech. ?With Intrexon you will have an exceptional opportunity to join the forefront of the bioindustrial revolution and contribute directly to the future of synthetic biology applications and products.

Please visit for further information on our company.

Key Statistics

Ownership: Private

Web Site: Intrexon Corporation (Research Triangle Park, NC)


Company News
Intrexon Corporation And Synthetic Biologics, Inc. (SYN) Enter ECC To Develop Novel Biotherapeutics For Treatment Of Phenylketonuria 8/10/2015 6:34:30 AM
Intrexon Corporation To Announce First Half And Second Quarter 2015 Financial Results And Host Conference Call On August 10th 8/3/2015 8:11:35 AM
Intrexon Corporation Announces Distribution Ratio For Distribution Of ZIOPHARM, Inc. Shares 6/5/2015 6:39:35 AM
Intrexon Corporation Announces New Sector Leader 6/2/2015 11:29:26 AM
Intrexon Corporation To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/27/2015 7:32:48 AM
Intrexon Corporation To Announce First Quarter 2015 Financial Results On Monday, May 11, 2015 5/4/2015 11:44:55 AM
The Biopharmaceutical Business Of Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Intrexon Corporation Announce Agreement For The Development And Commercialization Of CAR-T Therapy 3/30/2015 6:23:54 AM
Intrexon Corporation To Announce Fourth Quarter And Full Year 2014 Financial Results On Monday, March 2, 2015 2/23/2015 7:45:09 AM
Intrexon Corporation Prices Public Offering Of Common Stock 1/22/2015 8:10:46 AM
Intrexon Corporation Announces Proposed Public Offering Of Common Stock 1/21/2015 7:55:49 AM